医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Oscar Wylee Announces Opening of First 2 Stores in Western Australia

2019年07月08日 PM03:24
このエントリーをはてなブックマークに追加


 

PERTH, Australia

It is with great excitement that Oscar Wylee announces the opening of its first 2 stores in Western Australia. The stores cater to the optometry needs of Perth locals and showcase a range of affordable, high-quality eyewear products.

“From humble beginnings in 2012, Oscar Wylee has grown into a national chain of optometry stores. We are a family run company that looks to the long term with a strong vision of continued growth and dedicated service to our customers,” said Jack Teoh. Bob Teoh and Jack Teoh serve as Oscar Wylee’s co-CEOs . “We welcome you to visit our locations and join our mission to improve the quality of eyewear for all Australians.”

Oscar Wylee prides itself on its philanthropic initiative I CARE FOR EYECARE. For every pair of frames purchased, a portion is donated to someone in need. Oscar Wylee works with established organisations such as Sight For All who are committed to supporting individuals and communities impacted by visual impairment.

Oscar Wylee offers 2 pairs of glasses including standard single vision prescription for $199. Customers can choose from an option of optical frames, non-prescription sunglasses, or a mix of both. Oscar Wylee offers BLUE LIGHT FILTER lenses that block blue light and protect the eyes from digital devices.

Most health fund members may be eligible to claim a rebate on their prescription glasses. Type and level of cover varies in every insurance plan so make sure to check your plan.

Oscar Wylee stores are open nationwide from Monday to Sunday.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190707005072/en/

CONTACT

Oscar Wylee

(02) 8355 4646

info@oscarwylee.com

Ino Tumamao

(02) 8355 4646

pr@oscarwylee.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease